Browsing Archives of Author » «

Tough climate for charities as we approach the spending round conclusion

June 20, 2013


Our latest research expenditure data show that our members spend c £1.2 billion on UK research in 2012 and demonstrates the importance of continued government partnership.

It’s all about the ecosystem

June 5, 2013


I joined big names in science today to emphasise how important it is for the government to invest in science to maintain the UK’s vibrant ecosystem.

Clinical Trials – proportionate regulation is necessary but not sufficient

May 2, 2013


Last week we gave evidence to the Science and Technology Committee on barriers facing clinical trials and possible solutions to increase their effectiveness.

Meaningful open access – it’s the way you tell it

March 13, 2013


Curiosity, clarity and conviction - top tips for accessible, engaging science writing

Research, Anyone?

January 11, 2013


Patients who want to be involved in clinical research aren't given enough opportunities, according to a mystery shopper exercise from NIHR. So how can we make the NHS commitment to improving access work in practice?

The death of IPR?

October 12, 2012


GlaxoSmithKline has announced it will open up anonymised data from clinical trials for further research. Shar Nebhrajani argues that openness can lead to more innovation, and asks: is it time for new models of intellectual property rights?

Early access to drugs – it’s welcome but we need more

October 9, 2012


We have responded to the MHRA's proposals to introduce an Early Access to Medicines Scheme